動物用藥品添加劑市場的分析和至2035年的預測：按類型、產品類型、技術、應用、劑型、材料類型、製造流程、最終用戶、功能

全球動物用藥品輔料市場預計將從2025年的13億美元成長到2035年的19億美元，年複合成長率（CAGR）為4.1%。此市場結構較為一體化，其中粘合劑和填充劑約佔30%的市場佔有率，是主要細分市場，其次是防腐劑（25%）和溶劑（20%）。主要應用包括動物用藥品製劑、注射製劑和外用製劑，其中口服製劑最為突出。市場規模通常以噸為單位，預計在動物用藥品和寵物護理行業的推動下，市場需求將保持穩定成長。

在動物用藥品輔料市場中，「類型」細分非常重要，因為它根據輔料的化學性質和功能對其進行分類，例如粘合劑、填充劑和防腐劑。填充劑在該細分市場中佔據主導地位，因為它們廣泛用於增強獸藥製劑的體積和穩定性。需求的主要驅動力是製藥業對高效能藥物遞送系統的需求。從成長趨勢來看，能夠提高藥物療效和患者依從性的多功能輔料的需求不斷成長。

「應用」領域重點在於獸用輔料的多種用途，包括口服、外用和注射等製劑。口服製劑因其給藥方便且寵物飼主用藥依從性高，成為市場的主要動力。伴侶動物慢性病盛行率的上升和畜牧業的擴張是推動需求成長的主要因素。尤其值得一提的是，目前市場正日益關注開發能提高口服製劑中活性成分生物利用度的輔料。

區域概覽

北美憑藉其完善的動物保健基礎設施和強大的動物醫藥生產商網路，在獸用輔料市場佔據主導地位。伴侶動物照護的高支出、寵物日益「人性化」以及先進獸醫學的普及，是推動高品質輔料需求的主要因素。該地區還擁有健全的法規結構，強調藥品安全性和製劑品質，促進了專用添加劑的使用。此外，強大的研發能力以及製藥公司與原料供應商之間的合作，進一步推動了創新，確保了穩定的需求，並鞏固了該地區在市場上的主導地位。

亞太地區是動物用藥品輔料市場成長最快的地區，這主要得益於動物保健產業的快速擴張以及對畜牧和伴侶動物照護日益成長的關注。經濟發展和都市化促進了寵物飼養量的增加和獸醫服務的改善，帶動了對動物用藥品及相關輔料需求的成長。該地區畜牧業規模龐大，對安全有效的動物保健產品的需求不斷成長，也為其帶來了巨大的成長機會。此外，生產能力的提升，尤其是在印度和中國等國家，以及對獸醫研發投入的增加，都在加速區域市場的擴張。

主要趨勢和促進因素

對動物保健和先進動物用藥品的需求不斷成長：

寵物飼養量的增加和牲畜數量的成長，促使人們對動物健康日益關注，這成為動物用藥品輔料市場的主要驅動力。獸醫保健支出的增加以及對有效製劑需求的不斷成長，推動了對高品質藥用輔料的需求。此外，獸醫學的進步和製劑複雜性的增加，也使得人們需要使用特殊的輔料來提高藥物的穩定性、生物利用度和遞送效率。隨著全球對動物福利和疾病管理意識的不斷提高，對安全有效的獸藥的需求也在不斷成長，加速了市場上先進輔料的應用。

生物製藥和天然來源添加劑的應用日益廣泛：

生物製藥、疫苗和基於天然成分的製劑的興起，為動物用藥品輔料市場帶來了巨大的機會。市場對能夠支持先進藥物遞送系統並增強藥物穩定性的輔料的需求日益成長。此外，消費者對天然和永續成分的偏好也推動了植物來源輔料的研發。新興市場獸藥的擴張以及動物健康研究投入的增加，為市場開闢了更多成長途徑。這些趨勢促使生產商不斷創新並拓展產品系列，為市場的長期成長創造了強勁的機會。

目錄

第1章 執行摘要

第2章 市場亮點

第3章 市場動態

• 宏觀經濟分析
• 市場趨勢
• 市場促進因素
• 市場機會
• 市場限制因素
• 年複合均成長率：成長分析
• 影響分析
• 新興市場
• 技術藍圖
• 戰略框架

第4章 細分市場分析

• 市場規模及預測：依類型
  • 粘合劑
  • 稀釋劑
  • 崩散劑
  • 潤滑劑
  • 防腐劑
  • 溶劑
  • 塗層劑
  • 調味劑
  • 著色劑
  • 其他
• 市場規模及預測：依產品分類
  • 片劑
  • 膠囊
  • 注射藥物
  • 外用製劑
  • 粉末
  • 液體
  • 凝膠
  • 軟膏
  • 栓劑
  • 其他
• 市場規模及預測：依應用領域分類
  • 口服
  • 腸外給藥
  • 外用
  • 吸入
  • 眼科
  • 鼻子
  • 直腸
  • 經皮吸收
  • 頰黏膜
  • 其他
• 市場規模及預測：依類型
  • 固態
  • 液體
  • 半固態
  • 其他
• 市場規模及預測：依材料類型分類
  • 合成
  • 自然
  • 半合成
  • 其他
• 市場規模及預測：依最終用戶分類
  • 動物醫院
  • 動物研究所
  • 製藥公司
  • 契約製造公司
  • 其他
• 市場規模及預測：依功能分類
  • 穩定器
  • 乳化劑
  • 暫停
  • 增稠劑
  • 其他
• 市場規模及預測：依技術分類
  • 微膠囊化
  • 奈米科技
  • 緩釋
  • 其他
• 市場規模及預測：依製程分類
  • 製造業
  • 配方
  • 包裝
  • 其他

第5章 區域分析

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲地區
• 亞太地區
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲
  • 台灣
  • 亞太其他地區
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 義大利
  • 其他歐洲地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 撒哈拉以南非洲
  • 其他中東和非洲地區

第6章 市場策略

• 供需差距分析
• 貿易和物流限制
• 價格、成本和利潤率趨勢
• 市場滲透率
• 消費者分析
• 監管概述

第7章 競爭訊息

• 市場定位
• 市場占有率
• 競爭基準
• 大公司的策略

第8章 公司簡介

• BASF
• Dow Chemical Company
• Evonik Industries
• Ashland Global Holdings
• Clariant
• Croda International
• Archer Daniels Midland Company
• Roquette Freres
• FMC Corporation
• Kerry Group
• JRS Pharma
• Merck KGaA
• Colorcon
• Lubrizol Corporation
• Ingredion Incorporated
• Eastman Chemical Company
• Gattefosse
• MEGGLE Group
• DFE Pharma
• SEPPIC

第9章 關於我們

The global Veterinary Excipients Market is projected to grow from $1.3 billion in 2025 to $1.9 billion by 2035, at a compound annual growth rate (CAGR) of 4.1%. The Veterinary Excipients Market is characterized by a moderately consolidated structure, with the top segments being binders and fillers, accounting for approximately 30% of the market share, followed by preservatives at 25%, and solvents at 20%. Key applications include oral formulations, injectables, and topical applications, with oral formulations being the most prominent. The market volume is typically measured in metric tons, with a steady demand driven by the growth in veterinary pharmaceuticals and pet care industries.

In the Veterinary Excipients Market, the 'Type' segment is crucial as it categorizes excipients based on their chemical nature and functionality, such as binders, fillers, and preservatives. Fillers dominate this segment due to their widespread use in enhancing the bulk and stability of veterinary formulations. The demand is primarily driven by the pharmaceutical industry's need for effective drug delivery systems. Growth trends indicate a rising preference for multifunctional excipients that can improve drug efficacy and patient compliance.

The 'Application' segment highlights the diverse uses of excipients in veterinary medicine, including oral, topical, and injectable formulations. Oral applications lead the market, driven by the ease of administration and high compliance rates among pet owners. The increasing prevalence of chronic diseases in companion animals and the expansion of livestock farming are key factors boosting demand. Notably, there is a growing trend towards developing excipients that enhance the bioavailability of active ingredients in oral formulations.

Geographical Overview

North America dominates the veterinary excipients market due to its well-established animal healthcare infrastructure and strong presence of veterinary pharmaceutical manufacturers. High spending on companion animal care, increasing pet humanization, and widespread adoption of advanced veterinary treatments are key factors supporting demand for high-quality excipients. The region also benefits from stringent regulatory frameworks that emphasize drug safety and formulation quality, encouraging the use of specialized excipients. In addition, strong research and development capabilities and collaboration between pharmaceutical companies and ingredient suppliers further enhance innovation, ensuring consistent demand and reinforcing the region's leading position in the market.

Asia Pacific is the fastest-growing region in the veterinary excipients market, driven by rapid expansion of the animal health industry and increasing focus on livestock and companion animal care. Economic development and urbanization are contributing to higher pet ownership and improved veterinary services, which in turn increase demand for veterinary medicines and associated excipients. The region also offers strong growth opportunities due to large livestock populations and rising need for safe and effective animal healthcare products. Additionally, growing manufacturing capabilities, particularly in countries like India and China, along with increasing investments in veterinary research, are accelerating regional market expansion.

Key Trends and Drivers

Increasing Demand for Animal Healthcare and Advanced Veterinary Medicines:

The growing focus on animal health, driven by rising pet ownership and expanding livestock populations, is a key driver for the veterinary excipients market. Increasing expenditure on veterinary care and the need for effective drug formulations are boosting demand for high-quality excipients used in medicines. Additionally, advancements in veterinary pharmaceuticals and the growing complexity of formulations require specialized excipients for improved stability, bioavailability, and delivery. As awareness around animal welfare and disease management continues to rise globally, the demand for safe and efficient veterinary drugs is increasing, thereby accelerating the adoption of advanced excipients in the market.

Growing Adoption of Biologics and Natural Excipients:

The increasing shift toward biologics, vaccines, and natural ingredient-based formulations presents significant opportunities in the veterinary excipients market. With the rise of advanced therapies, there is growing demand for excipients that can support complex drug delivery systems and enhance stability. Additionally, consumer preference for natural and sustainable ingredients is encouraging the development of plant-based excipients. Expanding veterinary healthcare in emerging markets and increasing investments in animal health research are further opening new growth avenues. These trends are enabling manufacturers to innovate and expand their product portfolios, creating strong opportunities for long-term market expansion.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Application
• 2.4 Key Market Highlights by Form
• 2.5 Key Market Highlights by Material Type
• 2.6 Key Market Highlights by End User
• 2.7 Key Market Highlights by Functionality
• 2.8 Key Market Highlights by Technology
• 2.9 Key Market Highlights by Process

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Binders
  • 4.1.2 Diluents
  • 4.1.3 Disintegrants
  • 4.1.4 Lubricants
  • 4.1.5 Preservatives
  • 4.1.6 Solvents
  • 4.1.7 Coating Agents
  • 4.1.8 Flavoring Agents
  • 4.1.9 Coloring Agents
  • 4.1.10 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Tablets
  • 4.2.2 Capsules
  • 4.2.3 Injectables
  • 4.2.4 Topicals
  • 4.2.5 Powders
  • 4.2.6 Liquids
  • 4.2.7 Gels
  • 4.2.8 Ointments
  • 4.2.9 Suppositories
  • 4.2.10 Others
• 4.3 Market Size & Forecast by Application (2020-2035)
  • 4.3.1 Oral
  • 4.3.2 Parenteral
  • 4.3.3 Topical
  • 4.3.4 Inhalation
  • 4.3.5 Ophthalmic
  • 4.3.6 Nasal
  • 4.3.7 Rectal
  • 4.3.8 Transdermal
  • 4.3.9 Buccal
  • 4.3.10 Others
• 4.4 Market Size & Forecast by Form (2020-2035)
  • 4.4.1 Solid
  • 4.4.2 Liquid
  • 4.4.3 Semi-Solid
  • 4.4.4 Others
• 4.5 Market Size & Forecast by Material Type (2020-2035)
  • 4.5.1 Synthetic
  • 4.5.2 Natural
  • 4.5.3 Semi-Synthetic
  • 4.5.4 Others
• 4.6 Market Size & Forecast by End User (2020-2035)
  • 4.6.1 Veterinary Clinics
  • 4.6.2 Animal Research Institutes
  • 4.6.3 Pharmaceutical Companies
  • 4.6.4 Contract Manufacturing Organizations
  • 4.6.5 Others
• 4.7 Market Size & Forecast by Functionality (2020-2035)
  • 4.7.1 Stabilizers
  • 4.7.2 Emulsifiers
  • 4.7.3 Suspending Agents
  • 4.7.4 Thickening Agents
  • 4.7.5 Others
• 4.8 Market Size & Forecast by Technology (2020-2035)
  • 4.8.1 Microencapsulation
  • 4.8.2 Nanotechnology
  • 4.8.3 Controlled Release
  • 4.8.4 Others
• 4.9 Market Size & Forecast by Process (2020-2035)
  • 4.9.1 Manufacturing
  • 4.9.2 Formulation
  • 4.9.3 Packaging
  • 4.9.4 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Application
    • 5.2.1.4 Form
    • 5.2.1.5 Material Type
    • 5.2.1.6 End User
    • 5.2.1.7 Functionality
    • 5.2.1.8 Technology
    • 5.2.1.9 Process
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Application
    • 5.2.2.4 Form
    • 5.2.2.5 Material Type
    • 5.2.2.6 End User
    • 5.2.2.7 Functionality
    • 5.2.2.8 Technology
    • 5.2.2.9 Process
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Application
    • 5.2.3.4 Form
    • 5.2.3.5 Material Type
    • 5.2.3.6 End User
    • 5.2.3.7 Functionality
    • 5.2.3.8 Technology
    • 5.2.3.9 Process
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Application
    • 5.3.1.4 Form
    • 5.3.1.5 Material Type
    • 5.3.1.6 End User
    • 5.3.1.7 Functionality
    • 5.3.1.8 Technology
    • 5.3.1.9 Process
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Application
    • 5.3.2.4 Form
    • 5.3.2.5 Material Type
    • 5.3.2.6 End User
    • 5.3.2.7 Functionality
    • 5.3.2.8 Technology
    • 5.3.2.9 Process
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Application
    • 5.3.3.4 Form
    • 5.3.3.5 Material Type
    • 5.3.3.6 End User
    • 5.3.3.7 Functionality
    • 5.3.3.8 Technology
    • 5.3.3.9 Process
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Application
    • 5.4.1.4 Form
    • 5.4.1.5 Material Type
    • 5.4.1.6 End User
    • 5.4.1.7 Functionality
    • 5.4.1.8 Technology
    • 5.4.1.9 Process
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Application
    • 5.4.2.4 Form
    • 5.4.2.5 Material Type
    • 5.4.2.6 End User
    • 5.4.2.7 Functionality
    • 5.4.2.8 Technology
    • 5.4.2.9 Process
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Application
    • 5.4.3.4 Form
    • 5.4.3.5 Material Type
    • 5.4.3.6 End User
    • 5.4.3.7 Functionality
    • 5.4.3.8 Technology
    • 5.4.3.9 Process
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Application
    • 5.4.4.4 Form
    • 5.4.4.5 Material Type
    • 5.4.4.6 End User
    • 5.4.4.7 Functionality
    • 5.4.4.8 Technology
    • 5.4.4.9 Process
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Application
    • 5.4.5.4 Form
    • 5.4.5.5 Material Type
    • 5.4.5.6 End User
    • 5.4.5.7 Functionality
    • 5.4.5.8 Technology
    • 5.4.5.9 Process
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Application
    • 5.4.6.4 Form
    • 5.4.6.5 Material Type
    • 5.4.6.6 End User
    • 5.4.6.7 Functionality
    • 5.4.6.8 Technology
    • 5.4.6.9 Process
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Application
    • 5.4.7.4 Form
    • 5.4.7.5 Material Type
    • 5.4.7.6 End User
    • 5.4.7.7 Functionality
    • 5.4.7.8 Technology
    • 5.4.7.9 Process
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Application
    • 5.5.1.4 Form
    • 5.5.1.5 Material Type
    • 5.5.1.6 End User
    • 5.5.1.7 Functionality
    • 5.5.1.8 Technology
    • 5.5.1.9 Process
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Application
    • 5.5.2.4 Form
    • 5.5.2.5 Material Type
    • 5.5.2.6 End User
    • 5.5.2.7 Functionality
    • 5.5.2.8 Technology
    • 5.5.2.9 Process
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Application
    • 5.5.3.4 Form
    • 5.5.3.5 Material Type
    • 5.5.3.6 End User
    • 5.5.3.7 Functionality
    • 5.5.3.8 Technology
    • 5.5.3.9 Process
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Application
    • 5.5.4.4 Form
    • 5.5.4.5 Material Type
    • 5.5.4.6 End User
    • 5.5.4.7 Functionality
    • 5.5.4.8 Technology
    • 5.5.4.9 Process
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Application
    • 5.5.5.4 Form
    • 5.5.5.5 Material Type
    • 5.5.5.6 End User
    • 5.5.5.7 Functionality
    • 5.5.5.8 Technology
    • 5.5.5.9 Process
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Application
    • 5.5.6.4 Form
    • 5.5.6.5 Material Type
    • 5.5.6.6 End User
    • 5.5.6.7 Functionality
    • 5.5.6.8 Technology
    • 5.5.6.9 Process
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Application
    • 5.6.1.4 Form
    • 5.6.1.5 Material Type
    • 5.6.1.6 End User
    • 5.6.1.7 Functionality
    • 5.6.1.8 Technology
    • 5.6.1.9 Process
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Application
    • 5.6.2.4 Form
    • 5.6.2.5 Material Type
    • 5.6.2.6 End User
    • 5.6.2.7 Functionality
    • 5.6.2.8 Technology
    • 5.6.2.9 Process
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Application
    • 5.6.3.4 Form
    • 5.6.3.5 Material Type
    • 5.6.3.6 End User
    • 5.6.3.7 Functionality
    • 5.6.3.8 Technology
    • 5.6.3.9 Process
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Application
    • 5.6.4.4 Form
    • 5.6.4.5 Material Type
    • 5.6.4.6 End User
    • 5.6.4.7 Functionality
    • 5.6.4.8 Technology
    • 5.6.4.9 Process
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Application
    • 5.6.5.4 Form
    • 5.6.5.5 Material Type
    • 5.6.5.6 End User
    • 5.6.5.7 Functionality
    • 5.6.5.8 Technology
    • 5.6.5.9 Process

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 BASF
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Dow Chemical Company
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Evonik Industries
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Ashland Global Holdings
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Clariant
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Croda International
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Archer Daniels Midland Company
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Roquette Freres
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 FMC Corporation
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Kerry Group
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 JRS Pharma
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Merck KGaA
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Colorcon
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Lubrizol Corporation
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Ingredion Incorporated
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Eastman Chemical Company
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Gattefosse
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 MEGGLE Group
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 DFE Pharma
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 SEPPIC
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us